Immunome, Inc.
IMNM
$19.37
$2.2813.34%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.54% | -3.71% | 2.46% | 57.30% | 164.92% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 86.32% | 58.42% | 60.41% | -38.48% | 593.26% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.70% | -2.41% | 3.13% | 52.96% | 166.96% |
|
|
|||||
| Total Current Assets | 14.70% | -2.41% | 3.13% | 52.96% | 166.96% |
| Net Property, Plant & Equipment | 53.64% | 65.84% | 162.43% | 295.68% | 530.19% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 44.48% | 37.80% | 565.72% | 2,155.50% | 1,333.91% |
| Total Assets | 16.54% | 0.03% | 7.17% | 61.73% | 175.76% |
|
|
|||||
| Total Accounts Payable | 74.73% | -33.87% | 27.12% | 328.54% | 26.27% |
| Total Accrued Expenses | -6.09% | -11.17% | 58.59% | 343.63% | 871.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -79.68% | 12.72% |
| Total Finance Division Other Current Liabilities | -83.67% | -91.23% | -59.18% | -19.14% | -39.08% |
| Total Other Current Liabilities | -83.67% | -91.23% | -59.18% | -19.14% | -39.08% |
| Total Current Liabilities | -20.45% | -42.66% | 0.09% | 148.78% | 71.04% |
|
|
|||||
| Total Current Liabilities | -20.45% | -42.66% | 0.09% | 148.78% | 71.04% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 62.87% | 67.22% | 295.52% | 255.90% | 1,919.67% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -13.12% | -- |
| Total Liabilities | -15.56% | -36.24% | 4.05% | 106.14% | -51.78% |
|
|
|||||
| Common Stock & APIC | 41.80% | 35.48% | 35.54% | 103.37% | 377.33% |
| Retained Earnings | -51.14% | -54.68% | -58.22% | -131.49% | -234.57% |
| Treasury Stock & Other | -- | -1,300.00% | -175.00% | 159.09% | -- |
| Total Common Equity | 22.81% | 6.08% | 7.55% | 51.12% | 3,436.97% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 22.81% | 6.08% | 7.55% | 51.12% | 3,436.97% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 22.81% | 6.08% | 7.55% | 51.12% | 3,436.97% |
|
|
|||||